Cargando…
GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
BACKGROUND: Glutathione Peroxidase 4 (GPX4) is a key protein that inhibits ferroptosis. However, its biological regulation and mechanism in endometrial cancer (EC) have not been reported in detail. METHODS: The expression of GPX4 in EC tissues was determined by TCGA databases, qRT-PCR, Western blot,...
Autores principales: | Wei, Sitian, Yu, Zhicheng, Shi, Rui, An, Lanfen, Zhang, Qi, Zhang, Qian, Zhang, Tangansu, Zhang, Jun, Wang, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373394/ https://www.ncbi.nlm.nih.gov/pubmed/35962333 http://dx.doi.org/10.1186/s12885-022-09986-3 |
Ejemplares similares
-
Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer
por: Shi, Rui, et al.
Publicado: (2023) -
Development and Validation of a Novel Prognostic Model for Endometrial Cancer Based on Clinical Characteristics
por: Yu, Zhicheng, et al.
Publicado: (2021) -
Single‐cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer
por: Yu, Zhicheng, et al.
Publicado: (2022) -
N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer
por: Shi, Rui, et al.
Publicado: (2021) -
CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer
por: Zhang, Jun, et al.
Publicado: (2022)